Aardvark Therapeutics, Inc. Common Stock (AARD) NASDAQ

12.13

-0.15(-1.22%)

Updated at February 13 12:09PM

Currency In USD

Valuation

Market Cap184.73M
Enterprise Value123.87M
P/E Ratio-5.47
PEG Ratio0.3
Price/Sales Ratio0
Price/Book Ratio2.18
Enterprise/Revenue0
Enterprise/EBITDA-4.39

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.37
Return On Equity-0.55

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-22.65M
Net Income-20.59M
Diluted EPS-1.59

Balance Sheet

Total Cash126.35M
Total Cash/Share5.82
Total Debt545,000
Total Debt/Equity0
Current Ratio12.03
Book Value Per Share5.64

Price History

52-Week Change-14.19
52-Week High19.58
52-Week Low4.88
Moving Average 50 Days13.73
Moving Average 200 Days12.05

Statistics

Average Volume201,577
Shares Outstanding21.77M
% Held by Institutions43.62

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A